It’s critical to define for HCPs the problem your compound solves for them and their patients. Whether it’s underserved patient populations, suboptimal efficacy, or the burden of current therapies, each disease space has unique challenges. In order to create a change in thinking, the communication of these dynamics to HCPs must be both credible and impactful. CATALYST strikes this balance, making scientific disease education an art form.